BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22237985)

  • 1. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
    Lindström S; Schumacher FR; Cox D; Travis RC; Albanes D; Allen NE; Andriole G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gaziano JM; Giles GG; Giovannucci E; Gonzalez CA; Henderson B; Hunter DJ; Johansson M; Kolonel LN; Ma J; Le Marchand L; Pala V; Stampfer M; Stram DO; Thun MJ; Tjonneland A; Trichopoulos D; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Hayes RB; Severi G; Haiman CA; Chanock SJ; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):437-44. PubMed ID: 22237985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
    Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
    Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
    Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
    Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
    Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Multiple Cohort Datasets Deciphers the Utility of Germline Single-Nucleotide Polymorphisms in Prostate Cancer Diagnosis.
    Zhang W; Dong Y; Sartor O; Zhang K
    Cancer Prev Res (Phila); 2021 Jul; 14(7):741-752. PubMed ID: 33866309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.
    Sun J; Chang BL; Isaacs SD; Wiley KE; Wiklund F; Stattin P; Duggan D; Carpten JD; Trock BJ; Partin AW; Walsh PC; Grönberg H; Xu J; Isaacs WB; Zheng SL
    Prostate; 2008 Sep; 68(12):1257-62. PubMed ID: 18491292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
    Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
    Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
    Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
    Maas P; Barrdahl M; Joshi AD; Auer PL; Gaudet MM; Milne RL; Schumacher FR; Anderson WF; Check D; Chattopadhyay S; Baglietto L; Berg CD; Chanock SJ; Cox DG; Figueroa JD; Gail MH; Graubard BI; Haiman CA; Hankinson SE; Hoover RN; Isaacs C; Kolonel LN; Le Marchand L; Lee IM; Lindström S; Overvad K; Romieu I; Sanchez MJ; Southey MC; Stram DO; Tumino R; VanderWeele TJ; Willett WC; Zhang S; Buring JE; Canzian F; Gapstur SM; Henderson BE; Hunter DJ; Giles GG; Prentice RL; Ziegler RG; Kraft P; Garcia-Closas M; Chatterjee N
    JAMA Oncol; 2016 Oct; 2(10):1295-1302. PubMed ID: 27228256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
    Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
    PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
    Seibert TM; Fan CC; Wang Y; Zuber V; Karunamuni R; Parsons JK; Eeles RA; Easton DF; Kote-Jarai Z; Al Olama AA; Garcia SB; Muir K; Grönberg H; Wiklund F; Aly M; Schleutker J; Sipeky C; Tammela TL; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Wokolorczyk D; Kluzniak W; Cannon-Albright L; Brenner H; Cuk K; Saum KU; Park JY; Sellers TA; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; Karow DS; Mills IG; Andreassen OA; Dale AM;
    BMJ; 2018 Jan; 360():j5757. PubMed ID: 29321194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model to determine colorectal cancer risk using common genetic susceptibility loci.
    Hsu L; Jeon J; Brenner H; Gruber SB; Schoen RE; Berndt SI; Chan AT; Chang-Claude J; Du M; Gong J; Harrison TA; Hayes RB; Hoffmeister M; Hutter CM; Lin Y; Nishihara R; Ogino S; Prentice RL; Schumacher FR; Seminara D; Slattery ML; Thomas DC; Thornquist M; Newcomb PA; Potter JD; Zheng Y; White E; Peters U; ;
    Gastroenterology; 2015 Jun; 148(7):1330-9.e14. PubMed ID: 25683114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
    Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of incorporating genetic variants for the early detection of prostate cancer.
    Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
    Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population.
    Wei HM; Chen HT; Wang P; Wu YS; Na R; Liu F; Sun JS; Jiang DK; Lu DR; Xu J
    Asian J Androl; 2015; 17(1):168-70. PubMed ID: 25412674
    [No Abstract]   [Full Text] [Related]  

  • 17. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
    Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
    Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
    Bancroft EK; Page EC; Castro E; Lilja H; Vickers A; Sjoberg D; Assel M; Foster CS; Mitchell G; Drew K; Mæhle L; Axcrona K; Evans DG; Bulman B; Eccles D; McBride D; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Cybulski C; Wokolorczyk D; Selkirk C; Hulick PJ; Bojesen A; Skytte AB; Lam J; Taylor L; Oldenburg R; Cremers R; Verhaegh G; van Zelst-Stams WA; Oosterwijk JC; Blanco I; Salinas M; Cook J; Rosario DJ; Buys S; Conner T; Ausems MG; Ong KR; Hoffman J; Domchek S; Powers J; Teixeira MR; Maia S; Foulkes WD; Taherian N; Ruijs M; Helderman-van den Enden AT; Izatt L; Davidson R; Adank MA; Walker L; Schmutzler R; Tucker K; Kirk J; Hodgson S; Harris M; Douglas F; Lindeman GJ; Zgajnar J; Tischkowitz M; Clowes VE; Susman R; Ramón y Cajal T; Patcher N; Gadea N; Spigelman A; van Os T; Liljegren A; Side L; Brewer C; Brady AF; Donaldson A; Stefansdottir V; Friedman E; Chen-Shtoyerman R; Amor DJ; Copakova L; Barwell J; Giri VN; Murthy V; Nicolai N; Teo SH; Greenhalgh L; Strom S; Henderson A; McGrath J; Gallagher D; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Costello P; Eyfjord J; Rothwell J; Falconer A; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Kote-Jarai Z; Lubinski J; Axcrona U; Melia J; McKinley J; Mitra AV; Moynihan C; Rennert G; Suri M; Wilson P; Killick E; ; Moss S; Eeles RA
    Eur Urol; 2014 Sep; 66(3):489-99. PubMed ID: 24484606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Prediction of Prostate Cancer with Single Nucleotide Polymorphisms and Prostate Specific Antigen.
    Li-Sheng Chen S; Ching-Yuan Fann J; Sipeky C; Yang TK; Yueh-Hsia Chiu S; Ming-Fang Yen A; Laitinen V; Tammela TLJ; Stenman UH; Auvinen A; Schleutker J; Chen HH
    J Urol; 2019 Mar; 201(3):486-495. PubMed ID: 30366021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort.
    Cooperberg MR; Davicioni E; Crisan A; Jenkins RB; Ghadessi M; Karnes RJ
    Eur Urol; 2015 Feb; 67(2):326-33. PubMed ID: 24998118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.